Introduction
of the experimental results, their interpretation as well as the experimental conclusions that can be 108 drawn.
years (Table 1) , in this study. The patients were being treated for hypertension (n = 234, 17.8%), 113 hyperlipidemia (n = 173, 13.2%), diabetes mellitus (n = 80, 6.1%), and hyperuricemia (n = 70, 5.3%).
114
Malignant neoplasms were observed in 65 patients (5.0%; Table 1 ). Additionally, 85 patients were 115 receiving no treatments and no abnormal laboratory data. 
116

187
AST and BUN were also closely related to serum syndecan-1 concentrations in the current study.
188
Because syndecan-1 was found to enhance acute kidney injury in a previous report 
207
inflammatory cytokines and other insults; this mechanism was not evaluated in the current study.
208
Further studies are needed to explore these mechanisms.
209
Although several markers of the endothelial disorder have been reported, no biomarkers for 
340
on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitus. Diabetologia.
